# Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil

> **NCT01456299** · NA · COMPLETED · sponsor: **Gachon University Gil Medical Center** · enrollment: 102 (actual)

## Conditions studied

- Laryngismus

## Interventions

- **DRUG:** Remifentanil 1
- **DRUG:** Control
- **DRUG:** Remifentanil 2

## Key facts

- **NCT ID:** NCT01456299
- **Lead sponsor:** Gachon University Gil Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2019-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01456299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01456299, "Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01456299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*